Literature DB >> 3742181

Pancreatoduodenectomy with pylorus preservation for adenocarcinoma of the head of the pancreas.

P A Grace, H A Pitt, W P Longmire.   

Abstract

For many years, the classical Whipple procedure has been the standard operative treatment for resectable periampullary cancer. Recently, the pylorus preservation operation has also been applied to periampullary tumours. This newer procedure has potential advantages in terms of ease of performance and postoperative physiology, but has yet to be proved as an adequate cancer operation. We, therefore, undertook the present retrospective analysis to compare the outcome following the pylorus preservation operation (n = 13) with that of the classical Whipple resection (n = 13) in 26 patients with histologically proved adenocarcinoma of the head of the pancreas. The two groups of patients were comparable for age, sex, pre-operative laboratory data, and resected margins free from tumour. More patients undergoing the classical Whipple resection had Stage I disease (10 versus 4, P less than 0.05). However, this difference would not be significant if the two patients in the pylorus preservation group with carcinomas in situ were considered to have stage I disease. Mean tumour diameter in the pylorus preservation patient group (3.2 +/- 0.6 cm) was smaller (P less than 0.05) than in the classical Whipple group (4.1 +/- 1.0 cm) but more patients in the pylorus preservation group also had metastases to the regional lymph nodes (54 versus 23 per cent). Overall operative morbidity (31 per cent) and mortality (4 per cent) was acceptable and did not differ between the two groups. Five year actuarial survival for pylorus preservation (25 per cent) was comparable to that observed for the Whipple procedure in this and other series.

Entities:  

Mesh:

Year:  1986        PMID: 3742181     DOI: 10.1002/bjs.1800730824

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  34 in total

1.  Pylorus-preserving duodenopancreatectomy: long-term complications and comparison with the Whipple procedure.

Authors:  P Morel; P Mathey; H Corboud; O Huber; R A Egeli; A Rohner
Journal:  World J Surg       Date:  1990 Sep-Oct       Impact factor: 3.352

2.  Gastric emptying after pancreatoduodenectomy with total stomach preservation and selective proximal vagotomy.

Authors:  Y Watanabe; H Tsumura; H Sakurai; T Haba; S Ono; H Aonuma
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

Review 3.  Pylorus-preserving pancreaticoduodenectomy in the treatment of chronic pancreatitis.

Authors:  Ramon E Jimenez; Carlos Fernandez-Del Castillo; David W Rattner; Andrew L Warshaw
Journal:  World J Surg       Date:  2003-10-13       Impact factor: 3.352

4.  [Bile reflux after stomach resection--aggression or protection?].

Authors:  V Schumpelick; G Arlt
Journal:  Langenbecks Arch Chir       Date:  1991

5.  Routes of lymphatic drainage from the pancreas: a suggested segmentation.

Authors:  B Donatini; G Hidden
Journal:  Surg Radiol Anat       Date:  1992       Impact factor: 1.246

6.  Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas.

Authors: 
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

7.  A systematic study of the vascularisation of the pancreas.

Authors:  B Donatini
Journal:  Surg Radiol Anat       Date:  1990       Impact factor: 1.246

8.  Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry.

Authors:  M Carpelan-Holmström; S Nordling; E Pukkala; R Sankila; J Lüttges; G Klöppel; C Haglund
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

9.  Morbidity and mortality after radical and palliative pancreatic cancer surgery. Risk factors influencing the short-term results.

Authors:  K E Bakkevold; B Kambestad
Journal:  Ann Surg       Date:  1993-04       Impact factor: 12.969

10.  Staging of carcinoma of the pancreas and ampulla of Vater. Tumor (T), lymph node (N), and distant metastasis (M) as prognostic factors.

Authors:  K E Bakkevold; B Kambestad
Journal:  Int J Pancreatol       Date:  1995-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.